PIVOT and the challenges of localized prostate cancer care.

about

PIVOT and the challenges of localized prostate cancer care.

Item

http://www.wikidata.org/entity/Q36450800

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

PIVOT and the challenges of localized prostate cancer care.

@ast

PIVOT and the challenges of localized prostate cancer care.

@en

type

Item

label

PIVOT and the challenges of localized prostate cancer care.

@ast

PIVOT and the challenges of localized prostate cancer care.

@en

prefLabel

PIVOT and the challenges of localized prostate cancer care.

@ast

PIVOT and the challenges of localized prostate cancer care.

@en

P1476

PIVOT and the challenges of localized prostate cancer care.

@en

P2093

Aviva E Weinberg

http://www.w3.org/2001/XMLSchema#string

James D Brooks

http://www.w3.org/2001/XMLSchema#string

P2860

Prostate-cancer mortality at 11 years of follow-up.

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Radical prostatectomy versus observation for localized prostate cancer.

Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository.

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer.

Cause-specific mortality following radical prostatectomy.

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.

Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.

Causes of death after radical prostatectomy at a large tertiary center.

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

P304

141-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3978/J.ISSN.2223-4683.2012.08.01

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26816701

http://www.w3.org/2001/XMLSchema#string

P932

4708249

http://www.w3.org/2001/XMLSchema#string